Site icon International Bureau for Epilepsy

European Survey on Epilepsy & Pregnancy

IBE - International Epilepsy Support

IBE - International Epilepsy SupportWe need your help!

IBE is conducting a survey in Europe to understand how well informed women of childbearing age are on the risks involved in epilepsy and pregnancy and how well this information is understood. The survey is currently available in English, German, Georgian, Russian and Spanish.

Why?

We need to establish current demographics and the shortfall in knowledge in this very important area for both the mother and her unborn child.

The survey is the first part of a Europe-focused project on Epilepsy & Pregnancy, the results of which will inform on design and delivery of future interventions through the development of a multi-faceted toolkit. If Phase One is successful, the programme will be rolled out in other regions.

What next?

The result of the survey will inform us of the following:

  1. The experiences of women with epilepsy of child bearing age
  2. What are the areas in which the IBE needs to intervene
  3. What our intervention programme should look like.

What you can do?

If you are living in Europe and willing to participate in the survey, it will take no more than 8 minutes to complete. The survey is completely anonymous, and we will not be able to identify respondents.

Your input will be invaluable to us, so please do help by giving us 8 minutes of your time.

Survey Links:

English:
https://www.surveymonkey.com/r/X7G3QG7

Croatian:
https://www.surveymonkey.com/r/6XP6J3T

Czech:
https://www.surveymonkey.com/r/6RSFBN2

French:
https://fr.surveymonkey.com/r/DBXFNJ9

German:
https://de.surveymonkey.com/r/5X95LZD

Georgian:
https://www.surveymonkey.com/r/2D6PSZP

Greek:
https://www.surveymonkey.com/r/HCWYG9P

Italian:
https://www.surveymonkey.com/r/QJL8ZZX

Polish:
https://www.surveymonkey.com/r/RS3ZPZQ

Russian:
https://ru.surveymonkey.com/r/9L96MQT

Spanish:
https://es.surveymonkey.com/r/76CKF3P

 

The survey is supported by a funding grant provided by Sanofi Aventis Group.

Exit mobile version